Skip to Content

Pulse Biosciences Inc PLSE

Morningstar Rating
$8.71 +0.31 (3.69%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PLSE is trading at a 42% discount.
Price
$8.51
Fair Value
$24.88
Uncertainty
Extreme
1-Star Price
$14.77
5-Star Price
$8.85
Economic Moat
Wqfrb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PLSE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$8.40
Day Range
$8.579.09
52-Week Range
$2.3613.62
Bid/Ask
$7.68 / $7.79
Market Cap
$479.75 Mil
Volume/Avg
310,476 / 178,890

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
< 0.01%

Company Profile

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Growth
Total Number of Employees
61

Comparables

Valuation

Metric
PLSE
SWAV
ATEC
Price/Earnings (Normalized)
83.78
Price/Book Value
9.1918.0124.53
Price/Sales
17.043.46
Price/Cash Flow
51.86
Price/Earnings
PLSE
SWAV
ATEC

Financial Strength

Metric
PLSE
SWAV
ATEC
Quick Ratio
9.2810.611.86
Current Ratio
9.5011.762.86
Interest Coverage
26.24−10.23
Quick Ratio
PLSE
SWAV
ATEC

Profitability

Metric
PLSE
SWAV
ATEC
Return on Assets (Normalized)
−44.65%19.87%−9.89%
Return on Equity (Normalized)
−158.65%35.18%
Return on Invested Capital (Normalized)
−48.20%22.54%−9.94%
Return on Assets
PLSE
SWAV
ATEC
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncJrnwfqsgwDmbw$141.5 Bil
BDX
Becton Dickinson & CoJvtysbkyLqbywb$71.5 Bil
ALC
Alcon IncRbxhhkdpYwylg$40.7 Bil
CLPBY
Coloplast A/S ADRNsjgdsctlPpqn$30.4 Bil
RMD
ResMed IncVpmdwdjsblSwnbcb$29.1 Bil
WST
West Pharmaceutical Services IncQstgbsttbmMxm$29.0 Bil
BAX
Baxter International IncXyxvmyqxRxydkys$21.8 Bil
COO
The Cooper Companies IncBvxfdwfdRpcqkg$20.2 Bil
HOLX
Hologic IncQrbmtmbqFcwkmx$18.3 Bil
TFX
Teleflex IncVxwlCmd$10.6 Bil

Sponsor Center